753 results on '"Kodaira, Takeshi"'
Search Results
52. Impact of age for overall survival in head and neck sarcoma
53. Dosimetric analysis on computed tomography myelography based treatment planning in stereotactic body radiotherapy for spinal metastases
54. ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence
55. Recent trends of characteristics and treatments in adults with newly diagnosed brain metastases.
56. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer
57. FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study
58. Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma
59. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis
60. The impact of the COVID-19 pandemic on radiotherapy in Japan: nationwide surveys from May 2020 through June 2021
61. Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy
62. Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapy
63. Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma
64. Efficacy of virtual block objects in reducing the lung dose in helical tomotherapy planning for cervical oesophageal cancer: a planning study
65. High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
66. Rotational output and beam quality evaluations for helical tomotherapy with use of a third-party quality assurance tool
67. Human papillomavirus-related oropharyngeal carcinoma
68. 691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208
69. 41: Effect of reimbursement costs on the choice of modality for brain stereotactic radiosurgery in Japan
70. 40: Re-irradiation of stereotactic body radiotherapy for metastatic epidural spinal cord compression
71. 39: A single-center survey of 800 patients with newly diagnosed brain metastases from 2016 to 2021
72. Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial
73. Additional file 1 of Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)
74. Retrospective analysis of definitive radiotherapy for neck node metastasis from unknown primary tumor: Japanese Radiation Oncology Study Group study
75. Recursive Partitioning Analysis for New Classification of Patients With Esophageal Cancer Treated by Chemoradiotherapy
76. Insufficiency Fractures After Pelvic Radiation Therapy for Uterine Cervical Cancer: An Analysis of Subjects in a Prospective Multi-institutional Trial, and Cooperative Study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG)
77. The impact of the COVID-19 pandemic on radiotherapy in Japan: nationwide surveys from May 2020 through June 2021.
78. A case of severe hemoptysis after stereotactic body radiotherapy for peripherally located stage I non-small cell lung cancer
79. Patterns of Radiotherapy Practice for Patients With Cervical Cancer in Japan, 2003–2005: Changing Trends in the Pattern of Care Process
80. Prognostic Impact of the 6th and 7th American Joint Committee on Cancer TNM Staging Systems on Esophageal Cancer Patients Treated With Chemoradiotherapy
81. Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (
82. Systemic therapy for salivary gland malignancy: current status and future perspectives
83. Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma
84. Evaluation of a new acrylic-lead shielding device for peripheral dose reduction during cone-beam computed tomography
85. Clinical Usefulness of [(18)F] Fluoro-2-Deoxy- d-Glucose Uptake in 178 Head-and-Neck Cancer Patients With Nodal Metastasis Treated With Definitive Chemoradiotherapy: Consideration of Its Prognostic Value and Ability to Provide Guidance for Optimal Selection of Patients for Planned Neck Dissection
86. Changing trend in the patterns of pretreatment diagnostic assessment for patients with cervical cancer in Japan
87. Fully automated rigid image registration versus human registration in postoperative spine stereotactic body radiation therapy: a multicenter non-inferiority study
88. Radiation Therapy for Elderly Patients with Glottic Cancer
89. Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L)
90. Parotid gland dose reduction in the hippocampus avoidance whole-brain radiotherapy using helical tomotherapy
91. Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review
92. Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis
93. Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue
94. Long-term engraftment stability of umbilical cord blood cells preserved in −135 °C mechanical freezers
95. Comparison of atlas-based auto-segmentation accuracy for radiotherapy in prostate cancer
96. EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma
97. The Impact of Radiation Dose and Fractionation on Outcomes for Limited-Stage Small-Cell Lung Cancer
98. Retrospective analysis of definitive radiotherapy for patients with superficial esophageal carcinoma: Consideration of the optimal treatment method with a focus on late morbidity
99. Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus
100. Lung dose reduction in patients with stage III non-small-cell lung cancer using software that estimates patient-specific dose reduction feasibility
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.